Use of a liquid nicotine delivery product to promote smoking cessation

被引:0
作者
Nicholas Geimer
Carl E Olson
Deborah Baumgarten
James L Kepner
Martin C Mahoney
机构
[1] Medical College of Wisconsin,Department of Medical Oncology
[2] Columbia St. Mary's Hospital,Department of Radiation Oncology
[3] American Cancer Society,Statistics and Evaluation Center
[4] Roswell Park Cancer Institute,Departments of Health Behavior and Medicine
来源
BMC Public Health | / 10卷
关键词
Nicotine; Smoking Cessation; Bupropion; Nicotine Replacement Therapy; Varenicline;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 48 条
[1]  
Baker TB(2007)Time to first cigarette in the morning as an index of ability to quit smoking: implications for nicotine dependence Nicotine Tob Res 9 S555-570
[2]  
Piper ME(2008)Strategies for smoking cessation: what is new and what works? Expert Review of Respiratory Medicine 2 201-213
[3]  
McCarthy DE(2008)A clinical blueprint to accelerate the elimination of tobacco use Jama 299 2083-2085
[4]  
Bolt DM(2006)Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation: a randomized controlled trial JAMA 296 47-55
[5]  
Smith SS(2006)Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial JAMA 296 56-63
[6]  
Kim SY(2002)Smoking cessation trials targeted to racial and economic minority groups JAMA 288 497-499
[7]  
Colby S(2003)Measures of abstinence in clinical trials: issues and recommendations Nicotine Tob Res 5 13-25
[8]  
Conti D(2009)Adverse effects with use of nicotine replacement therapy among quitline clients Nicotine Tob Res 11 408-417
[9]  
Giovino GA(1990)Arterial-venous differences in plasma concentrations of nicotine after cigarette smoking JAMA 263 2049-2050
[10]  
Hatsukami D(undefined)undefined undefined undefined undefined-undefined